544 related articles for article (PubMed ID: 16731302)
1. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis.
Friedman AN; Moe SM; Perkins SM; Li Y; Watkins BA
Am J Kidney Dis; 2006 Jun; 47(6):1064-71. PubMed ID: 16731302
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.
Harris WS; Sands SA; Windsor SL; Ali HA; Stevens TL; Magalski A; Porter CB; Borkon AM
Circulation; 2004 Sep; 110(12):1645-9. PubMed ID: 15353491
[TBL] [Abstract][Full Text] [Related]
3. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
5. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
6. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids from fish oils and cardiovascular disease.
Holub DJ; Holub BJ
Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
[TBL] [Abstract][Full Text] [Related]
8. A restricted cubic spline approach to assess the association between high fat fish intake and red blood cell EPA + DHA content.
Sirot V; Dumas C; Desquilbet L; Mariotti F; Legrand P; Catheline D; Leblanc JC; Margaritis I
Nutr Metab Cardiovasc Dis; 2012 Apr; 22(4):318-26. PubMed ID: 20875947
[TBL] [Abstract][Full Text] [Related]
9. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients.
Harris WS; Reid KJ; Sands SA; Spertus JA
Am J Cardiol; 2007 Jan; 99(2):154-8. PubMed ID: 17223410
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing EPA+DHA levels in red blood cells in Japan.
Itomura M; Fujioka S; Hamazaki K; Kobayashi K; Nagasawa T; Sawazaki S; Kirihara Y; Hamazaki T
In Vivo; 2008; 22(1):131-5. PubMed ID: 18396795
[TBL] [Abstract][Full Text] [Related]
12. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
Rupp H; Rupp TP; Wagner D; Alter P; Maisch B
Herz; 2006 Dec; 31 Suppl 3():30-49. PubMed ID: 17575804
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of Atlantic salmon in the Chinese diet reduces cardiovascular disease risk markers in dyslipidemic adult men.
Zhang J; Wang C; Li L; Man Q; Song P; Meng L; Du ZY; Frøyland L
Nutr Res; 2010 Jul; 30(7):447-54. PubMed ID: 20797476
[TBL] [Abstract][Full Text] [Related]
14. Cardiac mortality is associated with low levels of omega-3 and omega-6 fatty acids in the heart of cadavers with a history of coronary heart disease.
Chattipakorn N; Settakorn J; Petsophonsakul P; Suwannahoi P; Mahakranukrauh P; Srichairatanakool S; Chattipakorn SC
Nutr Res; 2009 Oct; 29(10):696-704. PubMed ID: 19917448
[TBL] [Abstract][Full Text] [Related]
15. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors.
Murphy KJ; Meyer BJ; Mori TA; Burke V; Mansour J; Patch CS; Tapsell LC; Noakes M; Clifton PA; Barden A; Puddey IB; Beilin LJ; Howe PR
Br J Nutr; 2007 Apr; 97(4):749-57. PubMed ID: 17349088
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease prevention and treatment.
von Schacky C
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
18. The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
Rasmussen LE; Svensson M; Jørgensen KA; Schmidt EB; Christensen JH
Nutr Res; 2010 Aug; 30(8):535-40. PubMed ID: 20851307
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid is an independent predictor of all-cause mortality in hemodialysis patients.
Hamazaki K; Terashima Y; Itomura M; Sawazaki S; Inagaki H; Kuroda M; Tomita S; Hirata H; Inadera H; Hamazaki T
Am J Nephrol; 2011; 33(2):105-10. PubMed ID: 21196723
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD.
Sala-Vila A; Harris WS; Cofán M; Pérez-Heras AM; Pintó X; Lamuela-Raventós RM; Covas MI; Estruch R; Ros E
Br J Nutr; 2011 Aug; 106(3):425-31. PubMed ID: 21450116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
